- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04169529
Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic Obstructive Pulmonary Disease (COPD) is progressive and currently incurable and refers to a collection of diseases that lead to the key feature of irreversible airflow limitation and breathing related problems. Of those with COPD, 46% experienced at least one exacerbation within the previous year and 19% needed hospitalization. The financial burden of COPD is also evident, in that over $32 billion was spent for COPD care in the United States in 2010 and it is expected to be close to $50 billion in 2020.
Reducing healthcare utilization associated with COPD patient management (i.e. short-term readmission and chronic disease management) is a critically important unmet need for patients, caregivers, and hospitals. Early detection, prevention, and treatment of COPD exacerbation would aim to reduce this high morbidity and cost. To help reduce these exacerbations and improve disease management, sensors in a minimally invasive device can be used to identify factors that are associated with exacerbations.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Priya Raman, Ph.D.
- Phone Number: +1-763-505-9546
- Email: priyadarshini.raman@medtronic.com
Study Locations
-
-
Florida
-
Brandon, Florida, United States, 33511
- Bay Area Cardiology Associates
-
Jacksonville, Florida, United States, 32207
- Baptist Medical Center
-
Leesburg, Florida, United States, 34748
- Clinical Site Partners Inc
-
-
Georgia
-
Savannah, Georgia, United States, 31404
- Memorial Health University Medical Center
-
-
New Jersey
-
Marlton, New Jersey, United States, 08053
- Virtua Pulmonology Marlton
-
-
New York
-
New York, New York, United States, 10075
- Northwell Health Lenox Hill Hospital
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73120
- Oklahoma Cardiovascular Research Group
-
-
Pennsylvania
-
Lancaster, Pennsylvania, United States, 17604
- Lancaster General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient is ≥ 45 years old
- Patient (or patient's legally authorized representative) is willing and able to provide written informed consent
- Patient is willing and able to comply with the protocol, including follow-up visits, electronic diary submissions and CareLink transmissions
- FEV1 (post bronchodilator) ≤ 70% of predicted
- Current or former smoker with lifetime cigarette consumption of > 10 pack-years
- One COPD exacerbation in the previous 12 months requiring hospitalization, urgent care or emergency department visit for respiratory illness OR Two COPD exacerbations within the previous 12 months requiring antibiotics and/or corticosteroids for respiratory symptoms.
- The patient's medical records must be accessible by the enrolling site over the follow-up period
Exclusion Criteria:
- Less than 30 days from diagnosis of a COPD exacerbation as defined as taking antibiotics and/or corticosteroids for respiratory symptoms, hospitalization, urgent care or emergency department visit for respiratory illness.
Less than 30 days from diagnosis of a HF event as defined as any cardiovascular-related (including hypervolemia) Health Care Utilizations (HCUs) for any one of the following events:
- Admission with primary diagnosis of HF
Intravenous HF therapy (e.g. IV diuretics/vasodilators) or ultrafiltration at any one of the following settings:
- Admission with secondary/tertiary diagnosis of HF
- Emergency Department
- Ambulance
- Observation Unit
- Urgent Care
- HF/Cardiology Clinic
- Active respiratory infection being treated with antibiotics and/or corticosteroids
- Class IV heart failure
- Clinical diagnosis of unstable angina, bronchiectasis, or cystic fibrosis
- Any concomitant condition that might endanger the patient through participation in the study or interfere with study procedures, as assessed by the investigator
- Patient is pregnant (all females of child-bearing potential must have a negative pregnancy test within 1 week of enrollment)
- Patient is enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager
- Patient has an existing or planned implantation of Medtronic IPG, ICD, CRT-D or CRT-P device in the near future
- Patient has an existing and active insertable cardiac monitor, regardless of manufacturer
- Concurrent disease with life expectancy less than 1 year
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reveal LINQ™ derived data in patients with COPD
Time Frame: 24 months
|
Characterizing LINQ derived data with COPD events
|
24 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Christine Wendt, MD, U.S. Department of Veterans Affairs Minneapolis Healthcare System
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MDT19019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease (COPD) | COPDUnited Kingdom
-
Elpen Pharmaceutical Co. Inc.Completed
-
Rigshospitalet, DenmarkUnknown
Clinical Trials on Reveal LINQ
-
Medtronic Cardiac Rhythm and Heart FailureCompletedArrhythmias, CardiacUnited States, Belgium, Greece, Israel, Italy, Japan, Netherlands, Portugal, Saudi Arabia
-
University of Dublin, Trinity CollegeUniversity of Copenhagen; Medtronic Bakken Research CenterRecruitingFrailty | Fall PatientsIreland
-
Medtronic Cardiac Rhythm and Heart FailureCompletedStroke, AcuteUnited States
-
Oslo University HospitalVestre Viken Hospital Trust; Ullevaal University Hospital; Rigshospitalet, Denmark and other collaboratorsCompletedIschemic Stroke | Atrial Fibrillation | TIANorway
-
Northwell HealthCompletedIschemic StrokeUnited States
-
Northwell HealthMedtronicTerminatedGeneralized Epilepsy | Intractable Epilepsy | Focal Epilepsy | Epileptic Encephalopathy | Lennox Gastaut Syndrome | Symptomatic EpilepsyUnited States
-
University of AlbertaUniversity of Calgary; Alberta Innovates Health Solutions; MedtronicCompletedStroke | Atrial Fibrillation | Arrhythmias, CardiacCanada
-
Medtronic Cardiac Rhythm and Heart FailureTerminated
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
Newmarket Electrophysiology Research Group IncUnknownAtrial FibrillationCanada